Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects

Clinical trial NCT01543490 · COMPLETED

Trial details

NCT number: NCT01543490
Sponsor: Sun Pharmaceutical Industries Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Active, Symptomatic Blepharitis

Start date: 2018-03-30
Primary completion: 2020-02-04
Enrollment: 558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.